drugset / Trial / NCT00893971
Study to Evaluate Single Inhaled Doses of PT001, PT003, PT005 and PT001 Plus PT005 in Healthy Subjects
RandomizedCrossoverQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the safety of a single dose of PT003 compared with single doses of PT001 and PT005, and compared with PT001 plus PT005 delivered together as two separate single doses in healthy subjects.
Timeline
- Start
- 2009-05
- Primary completion
- 2009-07
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glycopyrrolate | Small molecule | 18 ug | Inhaled |
| Subject | PT003 | Unknown | 2.4 ug | Inhaled |
| Subject | PT003 | Unknown | 18 ug | Inhaled |
| Subject | PT005 | Unknown | 2.4 ug | Inhaled |
Indications
No indication recorded.